IL25 and neoplasm: For example, in a genetic mouse model of Apc mutation‐driven CRC, high IL‐25 expression (by tuft cells) and IL‐25R‐expressing tumour‐resident ILC2s are associated with impaired anti‐tumour responses and reduced survival [97].